Carol Gallagher
Investing Profile
Fund: $6.2B
Sector and stage focus
- Series B: Pharmaceuticals, Health & Hospital Services, Health IT
- general: Diverse Investors, Female Investors, San Francisco Bay Area
- Series A: Health IT, Pharmaceuticals, Health & Hospital Services
Recent investments by Carol Gallagher
Carol Gallagher has 7 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Good2Go, Inc. | Seed Round | Sep 2017 | $7M |
| Good2Go, Inc | Seed | Sep 2017 | $7M |
| Recludix Pharma | Series A | Nov 2021 | $60M |
| Metacrine | Series C | Jun 2018 | $65M |
| Pionyr Immunotherapeutics | Series B | Dec 2017 | $62M |
| Millendo Therapeutics | Series Unknown | Aug 2018 | $30M |
| Cleave Therapeutics | Series B | Aug 2016 | $37M |
Frequent co-investors
Carol Gallagher has co-invested with: Ruby Lee, Robert Garland.
Is Carol Gallagher a fit for your round?
Upload your pitch deck and see whether Carol Gallagher appears in your top 20 matches.
Find investors for your deck